Inovio Pharmaceuticals Inc
NASDAQ:INO
Balance Sheet
Balance Sheet Decomposition
Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc
Balance Sheet
Inovio Pharmaceuticals Inc
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
13
|
18
|
17
|
8
|
10
|
14
|
30
|
20
|
17
|
6
|
34
|
41
|
58
|
19
|
24
|
24
|
22
|
251
|
71
|
46
|
14
|
66
|
44
|
|
| Cash Equivalents |
1
|
13
|
18
|
17
|
8
|
10
|
14
|
30
|
20
|
17
|
6
|
34
|
41
|
58
|
19
|
24
|
24
|
22
|
251
|
71
|
46
|
14
|
66
|
44
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
15
|
17
|
0
|
10
|
2
|
13
|
8
|
19
|
53
|
105
|
86
|
104
|
58
|
67
|
161
|
330
|
207
|
131
|
28
|
14
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
3
|
3
|
7
|
17
|
6
|
4
|
2
|
19
|
8
|
12
|
2
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
3
|
3
|
7
|
16
|
6
|
3
|
1
|
19
|
5
|
2
|
0
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
3
|
10
|
2
|
0
|
0
|
|
| Other Current Assets |
2
|
0
|
0
|
1
|
1
|
1
|
0
|
4
|
1
|
1
|
1
|
3
|
3
|
2
|
3
|
4
|
3
|
3
|
40
|
39
|
51
|
5
|
3
|
3
|
|
| Total Current Assets |
3
|
14
|
18
|
18
|
24
|
29
|
15
|
45
|
23
|
32
|
16
|
59
|
99
|
172
|
125
|
138
|
88
|
94
|
471
|
448
|
315
|
153
|
98
|
61
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
5
|
7
|
9
|
18
|
16
|
27
|
24
|
29
|
18
|
14
|
12
|
9
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
7
|
9
|
18
|
16
|
27
|
24
|
29
|
18
|
14
|
12
|
9
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
0
|
3
|
4
|
5
|
7
|
10
|
13
|
16
|
19
|
22
|
21
|
16
|
17
|
|
| Intangible Assets |
2
|
2
|
2
|
6
|
7
|
6
|
10
|
13
|
11
|
9
|
7
|
6
|
5
|
4
|
8
|
6
|
5
|
4
|
3
|
3
|
2
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
4
|
4
|
4
|
4
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
9
|
12
|
11
|
9
|
11
|
10
|
12
|
20
|
20
|
11
|
9
|
6
|
5
|
4
|
2
|
3
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
26
|
1
|
1
|
1
|
2
|
2
|
|
| Other Assets |
0
|
0
|
0
|
4
|
4
|
4
|
4
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
16
+200%
|
21
+29%
|
29
+38%
|
36
+24%
|
40
+11%
|
39
-2%
|
81
+107%
|
56
-30%
|
61
+9%
|
45
-26%
|
88
+96%
|
132
+49%
|
214
+62%
|
174
-19%
|
187
+8%
|
131
-30%
|
144
+10%
|
540
+275%
|
496
-8%
|
349
-30%
|
171
-51%
|
113
-34%
|
74
-34%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
2
|
2
|
2
|
2
|
0
|
4
|
2
|
1
|
1
|
6
|
3
|
9
|
14
|
16
|
15
|
8
|
1
|
25
|
65
|
5
|
6
|
3
|
|
| Accrued Liabilities |
0
|
0
|
2
|
1
|
1
|
1
|
1
|
0
|
3
|
4
|
4
|
1
|
5
|
7
|
13
|
17
|
15
|
17
|
33
|
36
|
29
|
21
|
16
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
12
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
1
|
1
|
4
|
1
|
1
|
3
|
1
|
6
|
4
|
22
|
6
|
16
|
17
|
3
|
6
|
7
|
8
|
5
|
3
|
0
|
13
|
29
|
|
| Total Current Liabilities |
2
|
1
|
5
|
4
|
7
|
3
|
15
|
19
|
6
|
11
|
8
|
29
|
14
|
31
|
44
|
35
|
35
|
32
|
42
|
66
|
97
|
43
|
35
|
44
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
77
|
19
|
15
|
17
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
5
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
5
|
4
|
4
|
0
|
2
|
2
|
2
|
6
|
6
|
6
|
6
|
9
|
9
|
30
|
18
|
16
|
13
|
11
|
9
|
7
|
|
| Total Liabilities |
2
N/A
|
1
-30%
|
5
+357%
|
6
+2%
|
18
+223%
|
9
-51%
|
20
+127%
|
20
+1%
|
10
-52%
|
14
+44%
|
11
-22%
|
36
+232%
|
21
-43%
|
38
+86%
|
50
+32%
|
45
-11%
|
44
-1%
|
141
+218%
|
79
-44%
|
96
+22%
|
126
+31%
|
54
-58%
|
45
-17%
|
50
+12%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
53
|
76
|
88
|
114
|
129
|
140
|
153
|
177
|
195
|
210
|
230
|
296
|
332
|
361
|
435
|
523
|
620
|
740
|
906
|
1 210
|
1 488
|
1 623
|
1 730
|
1 815
|
|
| Additional Paid In Capital |
57
|
91
|
103
|
138
|
147
|
171
|
172
|
238
|
241
|
257
|
264
|
348
|
443
|
534
|
557
|
666
|
708
|
743
|
1 367
|
1 610
|
1 711
|
1 741
|
1 799
|
1 840
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Equity |
4
N/A
|
15
+304%
|
16
+3%
|
23
+51%
|
18
-23%
|
31
+71%
|
19
-38%
|
61
+217%
|
47
-23%
|
47
+2%
|
34
-27%
|
52
+53%
|
111
+112%
|
176
+58%
|
123
-30%
|
142
+16%
|
87
-39%
|
3
-96%
|
461
+13 325%
|
400
-13%
|
222
-44%
|
117
-47%
|
69
-42%
|
24
-65%
|
|
| Total Liabilities & Equity |
5
N/A
|
16
+199%
|
21
+29%
|
29
+38%
|
36
+24%
|
40
+11%
|
39
-2%
|
81
+107%
|
56
-30%
|
61
+9%
|
45
-26%
|
88
+96%
|
132
+49%
|
214
+62%
|
174
-19%
|
187
+8%
|
131
-30%
|
144
+10%
|
540
+275%
|
496
-8%
|
349
-30%
|
171
-51%
|
113
-34%
|
74
-34%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
5
|
5
|
6
|
6
|
8
|
8
|
8
|
16
|
18
|
21
|
23
|
36
|
69
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|